Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1989 Jul;80(7):627–631. doi: 10.1111/j.1349-7006.1989.tb01688.x

Inhibition of Multidrug‐resistant Human Tumor Growth in Athymic Mice by Anti‐P‐glycoprotein Monoclonal Antibodies

Takashi Tsuruo 1,✉, Hirofumi Hamada 1, Shigeo Sato 1, Yuji Heike 1
PMCID: PMC5917818  PMID: 2571602

Abstract

In an effort to devise an effective treatment for human drug‐resistant cancers, we have developed monoclonal antibodies, MRK16 and 17, reactive to the multidrug transporter protein, P‐glycoprotein. The monoclonal antibodies given intravenously effectively prevented tumor development in athymic mice inoculated subcutaneously with drug‐resistant human ovarian cancer cells 2780AD. Treatment with MRK16 induced rapid regression of established subcutaneous tumors and apparent cures of some animals. Complement‐dependent cytotoxicity (MRK16) and antibody‐dependent cell‐mediated cytolysis (MRK16 and 17) were observed with these antibodies. These monoclonal antibodies may have potential as treatment tools against multidrug resistant human tumors possessing the P‐glycoprotein.

Keywords: Multidrug resistance, Monoclonal antibody, P‐glycoprotein, Human tumor, Athymic mice

Full Text

The Full Text of this article is available as a PDF (313.7 KB).

REFERENCES

  • 1. ) Riordan , J. R. and Ling , V.Genetic and biochemical characterization of multidrug resistance . Pharmacol. Ther. , 28 , 51 – 75 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Tsuruo , T.Mechanisms of multidrug resistance and implications for therapy . Jpn. J. Cancer Res. , 79 , 285 – 296 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. ) Roninson I. B. ( ed. ). “ Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells “ New York , Plenum Publishing Corp. , in press ( 1989. ). [Google Scholar]
  • 4. ) Safa , A. R. , Glover , C. J. , Meyers , M. B. , Biedler , J. L. and Felsted , R. L.Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug‐resistant cells . J. Biol. Chem. , 261 , 6137 – 6140 ( 1986. ). [PubMed] [Google Scholar]
  • 5. ) Cornwell , M. M. , Safa , A. R. , Felsted , R. L. , Gottesman , M. M. and Pastan , I.Membrane vesicles from multidrug resistant human cancer cells contain a specific 150‐ to 170‐kDa protein detected by photoaffinity labeling . Proc. Natl. Acad. Sci. USA , 83 , 3847 – 3850 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. ) Hamada , H. and Tsuruo , T.Purification of the 170‐ to 180‐kilodalton membrane glycoprotein associated with multidrug resistance: the 170‐ to 180‐kilodalton membrane glycoprotein is an ATPase . J. Biol. Chem. , 263 , 1454 – 1458 ( 1988. ). [PubMed] [Google Scholar]
  • 7. ) Hamada , H. and Tsuruo , T.Characterization of the ATPase activity of the 170‐ to 180‐kilodalton membrane glycoprotein (P‐glycoprotein) associated with multidrug resistance . Cancer Res. , 48 , 4926 – 4932 ( 1988. ). [PubMed] [Google Scholar]
  • 8. ) Willingham , M. C. , Richert , N. D. , Cornwell , M. M. , Tsuruo , T. , Hamada , H. , Gottesman , M. M. and Pastan , I. H.Immunocytochemical localization of P170 at the plasma membrane of multidrug‐resistant human cells . J. Histochem. Cytochem. , 35 , 1451 – 1456 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Sugawara , L , Kataoka , L , Morishita , Y. , Hamada , H. , Tsuruo , T. , Itoyama , S. and Mori , S.Tissue distribution of P‐glycoprotein encoded by a multidrug‐resistant gene as revealed by a monoclonal antibody, MRK16 . Cancer Res. , 48 , 1926 – 1929 ( 1988. ). [PubMed] [Google Scholar]
  • 10. ) Shen , D‐W. , Fojo , A. , Roninson , I. B. , Chin , J. E. , Soffir , R. , Pastan , I. and Gottesman , M. M.Multidrug resistance in DNA mediated transformants is linked to transfer of the human mdr1 gene . Mol. Cell. Biol. , 6 , 4039 – 4045 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. ) Gros , P. , Neriah , U. B. , Croop , J. M. and Housman , D. E.Isolation and expression of a complementary DNA (mdr) that confers multidrug resistance . Nature , 323 , 728 – 731 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Ueda , K. , Cardarelli , C. , Gottesman , M. M. and Pastan , I.Expression of a full‐length cDNA for the human mdr1 (P‐glycoprotein) gene confers multidrug‐resistance . Proc. Natl. Acad. Sci. USA , 84 , 3004 – 3008 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. ) Bell , D. R. , Gerlach , J. H. , Kartner , N. , Buich , R. N. and Ling , V.Detection of P‐glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance . J. Clin. Oncol. , 3 , 311 – 315 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Fojo , A. T. , Ueda , K. , Slamon , D. J. , Poplack , D. G. , Gottesman , M. M. and Pastan , I.Expression of a multidrug‐resistance gene in human tumors and tissues . Proc. Natl, Acad. Sci. USA , 84 , 265 – 269 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. ) Tsuruo , T. , Sugimoto , Y. , Hamada , H. , Roninson , I. , Okumura , M. , Adachi , K. , Morishima , Y. and Ohno , R.Detection of multidrug resistance markers, P‐glycoprotein and mdr1 mRNA, in human leukemia cells . Jpn. J. Cancer Res. , 78 , 1415 – 1419 ( 1987. ). [PubMed] [Google Scholar]
  • 16. ) Hamada , H. and Tsuruo , T.Functional role for the 170‐to 180‐kDa glycoprotein specific to drug‐resistant tumor cells as revealed by monoclonal antibodies . Proc. Natl. Acad. Sci. USA , 83 , 7785 – 7789 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. ) Hamilton , T. C. , Young , R. C. and Ozols , R. F.Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches . Semin. Oncol. , 11 , 285 – 298 ( 1984. ). [PubMed] [Google Scholar]
  • 18. ) Rogan , A. M. , Hamilton , T. C. , Young , R. C. , Klecker , R. W. , Jr. and Ozols , R. F.Reversal of adriamycin resistance by verapamil in human ovarian cancer . Science , 224 , 994 – 996 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Hamada , H. and Tsuruo , T. “ Molecular and Cellular Biology of Multi‐drug Resistance in Tumor Cells ,“ ed. Roninson I. B. , Plenum Press; , New York , in press ( 1989. ). [Google Scholar]
  • 20. ) Herlyn , D. and Koprowski , H.IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells . Proc. Natl. Acad. Sci. USA , 79 , 4761 – 4765 ( 1982. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. ) Masui , H. , Kawamoto , T. , Sata , J. D. , Wolf , B. , Sato , G. and Mendelsohn , J.Growth inhibition of human tumor cells in athymic mice by anti‐epidermal growth factor receptor monoclonal antibodies . Cancer Res. , 44 , 1002 – 1007 ( 1984. ). [PubMed] [Google Scholar]
  • 22. ) Adams , D. O. , Hall , T. , Steplewski , Z. and Koprowski , H.Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody‐dependent cytolysis . Proc. Natl. Acad. Sci. USA , 81 , 3506 – 3510 ( 1984. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. ) Thiebaut , F. , Tsuruo , T. , Hamada , H. , Gottesman , M. M. , Pastan , I. and Willingham , M. C.Cellular localization of the multidrug‐resistance gene product P‐glycoprotein in normal human tissues . Proc. Natl. Acad. Sci. USA , 84 , 7735 – 7738 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. ) Sugawara , I. , Nakahama , M. , Hamada , H. , Tsuruo , T. and Mori , S.Apparent stronger expression in the human adrenal cortex than in the human adrenal medulla of M, 170,000–180,000 P‐glycoprotein . Cancer Res. , 48 , 4611 – 4614 ( 1988. ). [PubMed] [Google Scholar]
  • 25. ) Yang , C‐P. H. , DePinho , S. G. , Greenberger , L. M. , Arceci , R. J. and Horwitz , S. B.Progesterone interacts with P‐glycoprotein in multidrug‐resistant cells and in the endometrium of gravid uterus . J. Biol. Chem. , 264 , 782 – 788 ( 1989. ). [PubMed] [Google Scholar]
  • 26. ) Meeker , T. C. , Lowder , J. , Maloney , D. G. , Miller , R. A. , Thielemans , K. , Warnke , R. and Levy , R.A clinical trial of anti‐idiotype therapy for B cell malignancy . Blood , 65 , 1349 – 1363 ( 1985. ). [PubMed] [Google Scholar]
  • 27. ) Miller , R. A. , Lowder , J. , Meeker , T. C. , Brown , S. and Levy , R.Anti‐idiotypes in B‐cell tumor therapy . Natl. Cancer Inst. Monogr. , 3 , 131 – 134 ( 1987. ). [PubMed] [Google Scholar]
  • 28. ) Marx , J. L.Chimeric antibodies — which are part mouse and part human — may help solve the problems hindering the therapeutic use of monoclonal antibodies . Science , 229 , 455 – 456 ( 1987. ). [Google Scholar]
  • 29. ) Pastan , L , Willingham , M. C. and FitzGerald , D. J. P.Immunotoxins . Cell , 47 , 641 – 648 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 30. ) FitzGerald , D. J. , Willingham , M. C. , Cardarelli , C. O. , Hamada , H. , Tsuruo , T. , Gottesman , M. M. and Pastan , I.A monoclonal antibody‐Pseudomonas toxin conjugate that specifically kills multidrug‐resistant cells . Proc. Natl Acad. Soi. USA , 84 , 4288 – 4292 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. ) Shiloni , E. , Eisenthal , A. , Sachs , D. and Rosenberg , S. A.Antibody‐dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2 . J. Immunol. , 138 , 1992 – 1998 ( 1987. ). [PubMed] [Google Scholar]
  • 32. ) Kawase , L , Komuta , K. , Hara , H. , Inoue , T. , Hosoe , S. , Ikeda , T. , Shirasaka , T. , Yokota , S. , Tanio , Y. , Masuno , T. and Kishimoto , S.Combined therapy of mice bearing a lymphokine‐activated killer‐resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody‐dependent cellular cytotoxicity . Cancer Res. , 48 , 1173 – 1179 ( 1988. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES